Deltanoid Pharmaceuticals, Inc.; Deltanoid Pharmaceuticals Announces Appointment of Douglas Jermasek...
Deltanoid Pharmaceuticals, Inc.; Deltanoid Pharmaceuticals Announces Appointment of Douglas Jermasek as Chief Executive Officer
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Mr. [Douglas Jermasek] has over 20 years of biopharmaceutical industry experience. In his past role as Senior Vice President & General Manager of Genzyme/Sanofi's global renal business, he drove sales over $ billion, establishing Renvela((R)) as the standard of care for the treatment of hyperphosphatemia for patients with chronic kidney disease (CK...
Alternative Titles
Full title
Deltanoid Pharmaceuticals, Inc.; Deltanoid Pharmaceuticals Announces Appointment of Douglas Jermasek as Chief Executive Officer
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1764390497
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1764390497
Other Identifiers
ISSN
1543-6667
E-ISSN
1543-6675
